|
State Medicaid offices are targeting the homes of deceased individuals
to recoup healthcare costs, leading to legal battles and emotional
distress for families. While this practice varies widely among states, some
lawmakers and advocates argue that it perpetuates wealth disparities
and intergenerational poverty, calling for reforms to make the recovery
process optional rather than mandatory.
|
New data reveals that marriage rates surged in 2022 after a dip during
the Covid-19 lockdowns, reaching 6.2 marriages per 1,000 people.
Lockdowns forced couples to confront relationship issues, leading to more
intentional partnerships and potentially contributing to the decline in
divorce rates, which fell to 2.4 per 1,000 people in 2022. This trend reflects a
shift towards "companionate marriages," where partners prioritize qualities
conducive to long-term stability and satisfaction.
|
Senator Bernie Sanders has introduced a bill to shorten the standard
workweek in the US from 40 hours to 32 hours, arguing that
advancements in technology allow for more leisure time without
compromising pay and benefits. While proponents cite studies showing
increased job satisfaction and stable or improved revenues in some
companies with a 32-hour workweek, critics warn of potential productivity
losses, especially in industries requiring hands-on labor. Despite historical
roots in labor movements advocating for shorter workdays, bipartisan
support for such legislation remains uncertain in the current political
climate.
|
The introduction of zuranolone, a promising treatment for postpartum
depression, has raised questions about how insurers will handle
coverage for this novel and costly medication. While zuranolone offers
potential benefits for patients, including fast-acting relief, most private
health insurers have yet to establish coverage criteria, leaving patients
and providers uncertain about accessibility. Concerns persist based on
past restrictions, highlighting the need for transparent and equitable
access to novel mental health treatments
.
|
The over-the-counter availability of Narcan, designed to address opioid
overdoses, faces challenges in accessibility and visibility in stores
across the U.S., potentially limiting its impact amidst the ongoing opioid
crisis. While sales of the drug have increased, concerns persist regarding
pricing, stigma, and inconsistent availability, suggesting a need for
broader education and accessibility initiatives.
|
|